AVXL
Anavex Life Sciences Corp
2.40$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -96.5% | +1,178.9% | -99.8% | +28,776.0% | +5,560.7% | -19.3% | -38.4% | -93.5% | +2,891.3% | +1,769.0% | +110.4% | -38.6% | +193.1% | -12.4% | +3.9% | +36.4% | +367.9% | -5.5% | +1.1% | -12.2% | -23.4% | |
| – | -96.5% | +1,178.9% | -99.8% | +25,328.0% | +6,301.6% | -20.0% | -38.4% | -93.7% | +3,028.3% | +1,768.4% | +110.4% | -38.9% | +194.1% | -12.5% | +4.1% | +36.4% | +367.9% | -5.5% | +1.1% | -12.2% | -23.4% | |
| – | -96.5% | +1,156.4% | -99.8% | +25,328.0% | +5,421.4% | -24.6% | -49.1% | -91.6% | +2,937.1% | +2,004.5% | +110.6% | -39.9% | +198.7% | -16.4% | -3.2% | +31.8% | +420.0% | -1.9% | +1.3% | -12.5% | -22.4% | |
| – | -96.5% | +1,156.4% | -99.8% | +25,328.0% | +5,421.4% | -24.6% | -49.1% | -91.6% | +2,937.1% | +2,004.5% | +110.6% | -39.9% | +198.7% | -16.4% | -3.2% | +31.8% | +420.0% | -1.9% | +1.3% | -12.5% | -22.4% | |
| – | – | – | – | – | – | – | -97.9% | – | – | – | +0.0% | +3.3% | -87.7% | +19,087.1% | +41.3% | +83.5% | +88.4% | -65.1% | -15.2% | -9.6% | -67.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | – | -44.4% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +977.7% | +3.7% | +1,551.5% | +397.1% | +85.5% | -22.9% | -59.1% | +114.7% | -1.1% | +150.7% | -62.8% | +19.9% | +12.3% | +8.4% | +29.7% | +45.0% | +47.8% | -5.4% | +22.7% | +22.1% | -41.5% | |
| – | +977.7% | +3.7% | +1,551.5% | +397.1% | +78.2% | -19.7% | -59.1% | +114.7% | -32.4% | -26.2% | +84.6% | +19.9% | +12.3% | +8.4% | +29.7% | +45.0% | +47.8% | -5.4% | +22.7% | +22.1% | -41.5% | |
| – | – | – | – | – | +61.7% | -0.6% | -65.2% | -65.5% | -29.5% | -8.9% | -55.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -53.1% | +5,677.3% | +62.0% | +112.4% | -49.9% | -48.6% | -99.4% | +69,414.2% | -28.7% | +102.4% | +23.9% | +17.1% | -17.5% | +19.2% | +13.2% | +18.8% | -19.3% | +13.0% | +122.7% | -55.9% | |
| – | – | – | – | – | – | – | – | – | – | – | -99.9% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -201.6% | – | – | – | – | – | – | – | – | – | +6,549.7% | -50.8% | +284.5% | -15.5% | -1.0% | +34.2% | +453.7% | -5.5% | -0.4% | -15.2% | -21.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +127.3% | +10.4% | +0.0% | +2.6% | +2.5% | +6.1% | +17.4% | +11.9% | +13.3% | +22.9% | +89.5% | +89.1% | +16.2% | +9.3% | +9.5% | +19.0% | +19.9% | +10.2% | +3.7% | +4.6% | +2.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.